Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-26
SponsorJohns Hopkins University
About this trial
This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.
Eligibility criteria
Qualifiers
Able to verbalize pain scores
Oncology patients with acute and/or chronic pain
Disqualifiers
Patients with Implantable Devices
Epilepsy
Pregnancy
A history of myocardial infarction or ischemic heart disease within the past six months
Trial design
Treatments tested in this trial
- Scrambler Therapy MC-5A Device
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov